Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom

BACKGROUND: Botulinum toxin A (BoNT-A) is an effective treatment for patients with upper limb spasticity (ULS), which is a debilitating feature of upper motor neuron lesions. BoNT-A preparations available in the UK are associated with different costs. METHODS: We developed a budget impact model to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abogunrin, Seye, Hortobagyi, Linda, Remak, Edit, Dinet, Jerome, Gabriel, Sylvie, Bakheit, Abdel Magid O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386804/
https://www.ncbi.nlm.nih.gov/pubmed/25878510
http://dx.doi.org/10.2147/CEOR.S76141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386804/
https://www.ncbi.nlm.nih.gov/pubmed/25878510
http://dx.doi.org/10.2147/CEOR.S76141

Ejemplares similares